50 Results for "

NSC 20116

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "NSC 20116" in MCE Product Catalog:

95
95 Publications Verification
Cat. No.: HY-50898
CAS No.: 231277-92-2
Synonyms: GW572016; GW2016
Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
95
95 Publications Verification
Cat. No.: HY-50898A
CAS No.: 388082-77-7
Synonyms: GW572016 ditosylate; GW2016 ditosylate
Lapatinib ditosylate (GW572016 ditosylate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
95
95 Publications Verification
Cat. No.: HY-50898B
CAS No.: 388082-78-8
Synonyms: GW572016 ditosylate monohydrate; GW2016 ditosylate monohydrate
Target:  

EGFR Autophagy Ferroptosis

Research Areas:  

Infection Metabolic Disease Cancer

Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-16937
CAS No.: 1395347-24-6
Target:  

PI4P5K

Research Areas:  

Cancer

ISA-2011B is a PIP5K1α inhibitor with promising anticancer effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-154944
CAS No.: 2887480-87-5
Purity:  98.44%
Research Areas:  

Cancer

JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1) with an IC50 of 14.8 μM. JG-2016 can inhibit the growth of multiple tumor cells and has anti-tumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-76772
CAS No.: 153504-70-2
Synonyms: SNI-2011; AF102B hydrochloride hemihydrate
Target:  

mAChR

Research Areas:  

Neurological Disease Cancer

Cevimeline hydrochloride hemihydrate (SNI-2011) is a quinuclidine derivative of acetylcholine and a selective and orally active muscarinic M1 and M3 receptor agonist. Cevimeline hydrochloride hemihydrate stimulates secretion by the salivary glands and can be used as a sialogogue for xerostomia . Cevimeline hydrochloride hemihydrate can cross the blood-brain barrier (BBB) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1558A
CAS No.: 62232-46-6
Synonyms: MCI-2016
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Bifemelane hydrochloride (MCI-2016) is a potent, selective and competitive inhibitor of monoamine oxidase A (MAO-A), with a Ki of 4.20 μM. Bifemelane hydrochloride also inhibits MAO-B noncompetitively with a Ki of 46.0 μM. Bifemelane hydrochloride has a potent antidepressant activity and can be used for the research of cognitive and emotional disturbances related to cerebrovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19666
CAS No.: 97730-95-5
Synonyms: SDZ 201106
Target:  

Sodium Channel

Research Areas:  

Cardiovascular Disease

DPI 201-106 (SDZ 201106) is a cardiotonic agent with a synergistic sarcolemmal and intracellular mechanism of action. DPI 201-106 shows cardioselective modulation of voltage-gated sodium channels (VGSCs) resulting in a positive inotropic effect .
loading...
    loading...
Cat. No.: HY-P99382
CAS No.: 2039148-04-2
Synonyms: JTX 2011; 37A10

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology Cancer

Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab retains species cross-reactivity with affinities of 0.93 nM to hICOS, 0.46 nM to cynomolgus ICOS, 3.7 nM to rat ICOS, and 0.64 nM to mICOS. Vopratelimab has antitumor immune response .
loading...
    loading...
Cat. No.: HY-13540
CAS No.: 902128-92-1
Purity:  98.46%
Synonyms: GPI 21016
Target:  

PARP

Research Areas:  

Cancer

E7016 (GPI 21016) is an orally available PARP inhibitor. E7016 can enhance tumor cell radiosensitivity in vitro and in vivo through the inhibition of DNA repair. E7016 acts as a potential anticancer agent .
loading...
    loading...
Cat. No.: HY-50898S4
CAS No.: 1009307-23-6
Synonyms: GW572016-d7; GW2016-d7
Lapatinib-d7 (GW572016-d7) is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-164399
CAS No.: 1799802-29-1
Target:  

HSP EGFR CDK Akt

Research Areas:  

Cancer

SST0116CL1 is a HSP90 inhibitor (IC50: 0.21 μM). SST0116CL1 binds to the ATP binding pocket of Hsp90, and interferes with Hsp90 chaperone function thus resulting in client protein (EGFR, CDK4 and AKT) degradation. SST0116CL1 induces degradation of Her2 in BT-474 cell (IC50: 0.2 μM). SST0116CL1 has antiproliferative activity and inhibits tumor growth. SST0116CL1 can be used for the study of leukemia, gastric and ovarian carcinoma .
loading...
    loading...
Cat. No.: HY-136522
CAS No.: 2262489-89-2
Purity:  98.15%
Research Areas:  

Cancer

S2116, a N-alkylated tranylcypromine (TCP) derivative, is a potent lysine-specific demethylase 1 (LSD1) inhibitor. S2116 increases H3K9 methylation and reciprocal H3K27 deacetylation at super-enhancer regions. S2116 induces apoptosis in TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells by repressing transcription of the NOTCH3 and TAL1 genes. S2116 significantly retardes the growth of T-ALL cells in xenotransplanted mice .
loading...
    loading...
Cat. No.: HY-50898S1
Synonyms: GW572016-d7 dihydrochloride; GW2016-d7 dihydrochloride
Lapatinib-d7 dihydrochloride is the deuterium labeled Lapatinib dihydrochloride. Lapatinib (GW572016) dihydrochloride is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898S
CAS No.: 1184263-99-7
Synonyms: GW572016-d4; GW2016-d4
Lapatinib-d4 is the deuterium labeled Lapatinib (HY-50898). Lapatinib is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-124681
CAS No.: 1003000-59-6
Research Areas:  

Metabolic Disease

NY0116 is a neuromedin U receptor 2 (NMUR2) agonist with EC50 values of 27.76 μM for hNMUR1 and 13.61 μM for hNMUR2. NY0116 decreases cAMP while stimulating calcium signaling in stably expressing NMUR2 HEK293 cells .
loading...
    loading...
Cat. No.: HY-117854
CAS No.: 141311-11-7
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

SB 201146 is an LTB4 receptor antagonist with a potency range of 10 pM to 1 μM that plays a critical role in asthma-associated airway inflammation. Studies have focused on its effects on eosinophil survival, a hallmark of asthma pathology. Studies have shown that eosinophil-derived cysteinyl leukotrienes, including LTC4 and LTD4, as well as factors such as GM-CSF and fibronectin promote eosinophil survival. SB 201146 effectively reversed mast cell- and lymphocyte-induced eosinophil survival, highlighting its potential therapeutic role in disrupting the autocrine cysteinyl leukotriene pathway that maintains eosinophil viability. This antagonist also highlights the importance of LTB4 as a paracrine mediator that influences eosinophil survival in inflammatory settings such as asthma .
loading...
    loading...
Cat. No.: HY-19666R
CAS No.: 97730-95-5
Synonyms: SDZ 201106 (Standard)
DPI 201-106 (Standard) is the analytical standard of DPI 201-106. This product is intended for research and analytical applications. DPI 201-106 (SDZ 201106) is a cardiotonic agent with a synergistic sarcolemmal and intracellular mechanism of action. DPI 201-106 shows cardioselective modulation of voltage-gated sodium channels (VGSCs) resulting in a positive inotropic effect .
loading...
    loading...
Cat. No.: HY-107559
CAS No.: 152241-24-2
Target:  

Histamine Receptor

Research Areas:  

Neurological Disease

GT-2016 is a potent, selective, and brain penetrant histamine H3 receptor antagonist with a Ki of 43.8 nM. GT-2016 displays selectivity against H1 and H2 receptors, and has non-active against histamine methyltransferase .
loading...
    loading...
Cat. No.: HY-157479
CAS No.: 2760731-35-7
Target:  

Bacterial

Research Areas:  

Infection

DPI-2016 is a antibacterial agent. DPI-2016 shows improved bactericidal activity (MIC, 0.25-8 μg/mL) against all bacterial strains compared to the aztreonam (HY-B0129) (MIC, 16->64 μg/mL) .
loading...
    loading...